Allen Baharaff - 18 Mar 2026 Form 3 Insider Report for Galmed Pharmaceuticals Ltd. (GLMD)

Role
Chief Executive Officer, Director
Signature
/s/ Allen Baharaff
Issuer symbol
GLMD
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 07:45:48 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Baharaff Allen Chief Executive Officer, Director C/O MEITAR LAW OFFICES, 16 ABBA HILLEL SILVER RD., RAMAT GAN, ISRAEL /s/ Allen Baharaff 18 Mar 2026 0001630334

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding GLMD Ordinary Shares 103,047 18 Mar 2026 Direct
holding GLMD Ordinary Shares 18 18 Mar 2026 See Footnote F1
holding GLMD Restricted Share Units 8,889 18 Mar 2026 Direct F2
holding GLMD Restricted Share Units 96,666 18 Mar 2026 Direct F3
holding GLMD Restricted Share Units 100,000 18 Mar 2026 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GLMD Options to Purchase Ordinary Shares 18 Mar 2026 Ordinary Shares 1,222 $599.40 Direct
holding GLMD Options to Purchase Ordinary Shares 18 Mar 2026 Ordinary Shares 1,222 $921.60 Direct
holding GLMD Options to Purchase Ordinary Shares 18 Mar 2026 Ordinary Shares 1,222 $2080.80 Direct
holding GLMD Options to Purchase Ordinary Shares 18 Mar 2026 Ordinary Shares 1,805 $0.002000 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ordinary shares beneficially owned by Reporting Person's spouse.
F2 These restricted share units vest on August 7, 2026, subject to the Reporting Person's continued service.
F3 These restricted share units vest in four equal installments on each of May 12, 2026, November 12, 2026, May 12, 2027 and November 12, 2027, subject to the Reporting Person's continued service.
F4 These restricted share units vest in accordance with the following vesting schedule: 1/3 shall vest on August 26, 2026 and the remaining portion shall vest in four equal installments on each of February 26, 2027, August 26, 2027, February 26, 2028 and August 26, 2028, subject to the Reporting Person's continued service.